• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The Value of Establishing the Quantitative Accuracy of PET/CT Imaging.

作者信息

Kinahan Paul E, Mankoff David A, Linden Hannah M

机构信息

Department of Radiology, University of Washington, Seattle, Washington

Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania; and.

出版信息

J Nucl Med. 2015 Aug;56(8):1133-4. doi: 10.2967/jnumed.115.159178. Epub 2015 Jun 18.

DOI:10.2967/jnumed.115.159178
PMID:26089552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5278514/
Abstract
摘要

相似文献

1
The Value of Establishing the Quantitative Accuracy of PET/CT Imaging.建立PET/CT成像定量准确性的价值。
J Nucl Med. 2015 Aug;56(8):1133-4. doi: 10.2967/jnumed.115.159178. Epub 2015 Jun 18.
2
Repeatability of Tumor SUV Quantification: The Role of Variable Blood SUV.肿瘤SUV定量的可重复性：可变血液SUV的作用。
J Nucl Med. 2015 Oct;56(10):1635-6. doi: 10.2967/jnumed.115.161570. Epub 2015 Jun 25.
3
Reply: Repeatability of Tumor SUV Quantification: The Role of Variable Blood SUV.回复：肿瘤SUV定量的可重复性：可变血液SUV的作用。
J Nucl Med. 2015 Oct;56(10):1636. doi: 10.2967/jnumed.115.162271. Epub 2015 Aug 6.
4
[Significance of 8F-FDG PET-CT standard uptake value in clinical target delineation for radiotherapy of the primary tumor of non-small cell lung carcinoma].[8F-FDG PET-CT标准摄取值在非小细胞肺癌原发肿瘤放射治疗临床靶区勾画中的意义]
Zhonghua Zhong Liu Za Zhi. 2007 Dec;29(12):945-6.
5
Role of 18F-FDG PET in assessment of response in non-small cell lung cancer.18F-FDG PET在评估非小细胞肺癌疗效中的作用。
J Nucl Med. 2009 May;50 Suppl 1:31S-42S. doi: 10.2967/jnumed.108.057216. Epub 2009 Apr 20.
6
PET/CT in non-small cell lung cancer staging-promises and problems.PET/CT在非小细胞肺癌分期中的前景与问题
Clin Radiol. 2007 Feb;62(2):97-108. doi: 10.1016/j.crad.2006.09.015.
7
Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.F18-氟脱氧葡萄糖正电子发射断层扫描-计算机断层扫描在非小细胞肺癌潜在根治性手术后患者中的临床价值：241例患者的经验
Interact Cardiovasc Thorac Surg. 2010 Jun;10(6):1009-14. doi: 10.1510/icvts.2009.227538. Epub 2010 Mar 2.
8
Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.非小细胞肺癌：18F-FDG PET/CT 与单纯 CT 在术前分期中的前瞻性比较
Radiology. 2005 Sep;236(3):1011-9. doi: 10.1148/radiol.2363041310. Epub 2005 Jul 12.
9
Diagnostic accuracy of virtual 18F-FDG PET/CT bronchoscopy for the detection of lymph node metastases in non-small cell lung cancer patients.虚拟 18F-FDG PET/CT 支气管镜检查对非小细胞肺癌患者淋巴结转移的诊断准确性。
J Nucl Med. 2011 Oct;52(10):1520-5. doi: 10.2967/jnumed.111.092593. Epub 2011 Sep 9.
10
Mediastinal staging in Non-Small-Cell Lung Carcinoma: computed tomography versus F-18-fluorodeoxyglucose positron-emission tomography and computed tomography.非小细胞肺癌的纵隔分期：计算机断层扫描与F-18-氟脱氧葡萄糖正电子发射断层扫描及计算机断层扫描对比
Cancer Imaging. 2014 Jun 3;14(1):23. doi: 10.1186/1470-7330-14-23.

引用本文的文献

1
Report of the Medical Image De-Identification (MIDI) Task Group -- Best Practices and Recommendations.医学图像去识别化（MIDI）任务组报告——最佳实践与建议
ArXiv. 2025 Mar 16:arXiv:2303.10473v3.
2
Biology-guided radiotherapy: redefining the role of radiotherapy in metastatic cancer.生物学引导的放疗：重新定义放疗在转移性癌症中的作用。
Br J Radiol. 2021 Jan 1;94(1117):20200873. doi: 10.1259/bjr.20200873. Epub 2020 Oct 30.
3
Impact of an 18F-FDG PET/CT Radiotracer Injection Infiltration on Patient Management-A Case Report.18F-FDG PET/CT放射性示踪剂注射渗漏对患者管理的影响——病例报告
Front Med (Lausanne). 2018 May 15;5:143. doi: 10.3389/fmed.2018.00143. eCollection 2018.
4
NiftyPET: a High-throughput Software Platform for High Quantitative Accuracy and Precision PET Imaging and Analysis.NiftyPET：高通量软件平台，用于实现高定量准确性和高精度 PET 成像和分析。
Neuroinformatics. 2018 Jan;16(1):95-115. doi: 10.1007/s12021-017-9352-y.
5
Prognostic value of microRNAs in osteosarcoma: A meta-analysis.微小RNA在骨肉瘤中的预后价值：一项荟萃分析。
Oncotarget. 2017 Jan 31;8(5):8726-8737. doi: 10.18632/oncotarget.14429.
6
Towards real-time topical detection and characterization of FDG dose infiltration prior to PET imaging.迈向在PET成像前对FDG剂量浸润进行实时局部检测与特征分析。
Eur J Nucl Med Mol Imaging. 2016 Dec;43(13):2374-2380. doi: 10.1007/s00259-016-3477-3. Epub 2016 Aug 25.

本文引用的文献

1
Repeatability of 18F-FDG PET/CT in Advanced Non-Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials.18F-FDG PET/CT在晚期非小细胞肺癌中的重复性：两项多中心试验的前瞻性评估
J Nucl Med. 2015 Aug;56(8):1137-43. doi: 10.2967/jnumed.114.147728. Epub 2015 Apr 23.
2
Summary of the UPICT Protocol for 18F-FDG PET/CT Imaging in Oncology Clinical Trials.肿瘤临床试验中18F-FDG PET/CT成像的UPICT方案总结。
J Nucl Med. 2015 Jun;56(6):955-61. doi: 10.2967/jnumed.115.158402. Epub 2015 Apr 16.
3
A new initiative on precision medicine.一项关于精准医学的新倡议。
N Engl J Med. 2015 Feb 26;372(9):793-5. doi: 10.1056/NEJMp1500523. Epub 2015 Jan 30.
4
How to make more published research true.如何让更多已发表的研究成果真实可靠。
PLoS Med. 2014 Oct 21;11(10):e1001747. doi: 10.1371/journal.pmed.1001747. eCollection 2014 Oct.
5
Translational research in oncology--10 years of progress and future prospects.肿瘤学转化研究——十年的进展与未来展望。
Nat Rev Clin Oncol. 2014 Nov;11(11):649-62. doi: 10.1038/nrclinonc.2014.158. Epub 2014 Oct 7.
6
Role of PET quantitation in the monitoring of cancer response to treatment: Review of approaches and human clinical trials.PET定量在监测癌症治疗反应中的作用：方法与人体临床试验综述。
Clin Transl Imaging. 2014 Aug 1;2(4):295-303. doi: 10.1007/s40336-014-0071-1.
7
The Quantitative Imaging Network: NCI's Historical Perspective and Planned Goals.定量成像网络：NCI 的历史视角和计划目标。
Transl Oncol. 2014 Feb 1;7(1):1-4. doi: 10.1593/tlo.13832. eCollection 2014 Feb.
8
Molecular imaging biomarkers for oncology clinical trials.肿瘤临床研究的分子影像生物标志物。
J Nucl Med. 2014 Apr;55(4):525-8. doi: 10.2967/jnumed.113.126128. Epub 2014 Mar 10.
9
Cancer statistics, 2014.癌症统计数据，2014 年。
CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29. doi: 10.3322/caac.21208. Epub 2014 Jan 7.
10
18F-FDG PET/CT for early prediction of response to neoadjuvant lapatinib, trastuzumab, and their combination in HER2-positive breast cancer: results from Neo-ALTTO.18F-FDG PET/CT 用于预测 HER2 阳性乳腺癌患者接受新辅助拉帕替尼、曲妥珠单抗及其联合治疗的早期疗效：Neo-ALTTO 研究结果。
J Nucl Med. 2013 Nov;54(11):1862-8. doi: 10.2967/jnumed.112.119271. Epub 2013 Oct 3.